SSRIs cause sexual dysfunction through several overlapping mechanisms: they flood the brain with serotonin, which directly suppresses sexual desire and arousal, while simultaneously lowering testosterone and restricting blood flow to the genitals. This affects somewhere between 58 and 73% of people taking these medications, making it one of the most common side effects of antidepressant treatment.
How Serotonin Disrupts the Sexual Response
SSRIs work by keeping more serotonin available in the brain. That’s helpful for mood, but serotonin also acts as a brake on sexual function. When serotonin binds to certain receptors in the brain (called 5-HT2 receptors), it directly decreases libido. This is a pharmacological effect, not a psychological one. The same chemical mechanism that eases depression also dampens the brain’s interest in sex.
The problem extends beyond the brain. Higher serotonin levels in the body inhibit nitric oxide, a molecule that relaxes blood vessels and increases blood flow to the genitals. Without adequate nitric oxide, arousal becomes physically harder to achieve. In men, this can mean difficulty getting or maintaining an erection. In women, it can reduce genital sensation and natural lubrication. Both sexes commonly report difficulty reaching orgasm or a muted, unsatisfying quality to orgasm when they can.
The Hormonal Shift
SSRIs also change your hormonal landscape. All six of the most widely prescribed SSRIs have been shown to decrease testosterone production, though through slightly different biochemical pathways. In men, SSRI use is associated with lower testosterone, lower luteinizing hormone (which signals the body to produce testosterone), and elevated prolactin. Prolactin is the same hormone that surges after orgasm and creates that “satisfied, not interested” feeling. Chronically elevated prolactin suppresses sexual desire in a sustained way.
These hormonal changes compound the serotonin effects. You’re getting hit from multiple angles: less desire from the brain, less physical arousal from reduced blood flow, and a hormonal profile that further dampens interest in sex.
Why the Real Numbers Are Likely Higher
The commonly cited range of 58 to 73% already sounds high, but actual rates are probably worse. Sexual dysfunction is notoriously underreported because both patients and clinicians are reluctant to bring it up. Many people assume the problem is personal rather than pharmaceutical, or they feel too uncomfortable to mention it. Depression itself can reduce sexual desire and functioning in 25 to 75% of people even without medication, which makes it easy to attribute the side effect to the underlying condition rather than the drug.
When studies rely on patients spontaneously reporting problems, rates can appear as low as 4%. When researchers ask directly and systematically, the numbers jump to 80%. The gap between those figures tells you how much goes unspoken in a typical appointment.
Which SSRIs Are Worse
All SSRIs carry significant risk, but they’re not equal. Paroxetine (Paxil) has the highest rate of sexual side effects among SSRIs. Citalopram, escitalopram, fluoxetine, and sertraline all rank in the high-risk category as well. Notably, no SSRI appears on the list of antidepressants with the lowest rates of sexual side effects. That list is populated by medications from other classes: bupropion (Wellbutrin), mirtazapine (Remeron), and a few newer drugs that work through different mechanisms.
This distinction matters if you’re weighing treatment options. The sexual side effects aren’t a quirk of one particular SSRI. They’re baked into how the entire drug class works.
When Side Effects Appear and Whether They Fade
Sexual side effects typically show up within the first few weeks of starting an SSRI, often alongside other early side effects like nausea or headaches. The difference is that while nausea tends to resolve, sexual dysfunction frequently persists for as long as you take the medication. Some people do experience gradual improvement over months, so waiting it out is sometimes reasonable. But for many, the problem stays put.
Options if You’re Affected
The most common strategies involve adjusting your treatment rather than simply tolerating the side effect. Switching to an antidepressant with a different mechanism, like bupropion, is one approach. Bupropion works on dopamine and norepinephrine rather than serotonin, so it largely sidesteps the sexual side effects. Some clinicians add bupropion alongside an SSRI specifically to counteract the sexual dysfunction while keeping the mood benefits intact.
Another approach is a “drug holiday,” where you skip doses over the weekend. A small study of 30 patients found that stopping the SSRI after Thursday’s dose, resuming on Sunday, and scheduling sexual activity during that window improved function for some people. This works best with shorter-acting SSRIs like sertraline, and it’s not without risk. Skipping doses can cause withdrawal symptoms or mood instability, so this isn’t something to try without your prescriber’s input.
Dose reduction is sometimes effective. Sexual side effects are often dose-dependent, so finding the lowest effective dose for mood can reduce the impact on sexual function. Timing adjustments, like taking the medication after rather than before sexual activity, help a small number of people.
When It Doesn’t Go Away After Stopping
For a small but real subset of people, sexual dysfunction persists even after they stop taking the medication entirely. This condition, known as Post-SSRI Sexual Dysfunction (PSSD), involves ongoing symptoms like genital numbness, erectile dysfunction, inability to orgasm, or orgasms that feel flat and joyless. Some people with PSSD also report emotional blunting, reduced ability to feel pleasure, and apathy.
The estimated risk is roughly 1 in 216 patients treated with serotonergic antidepressants, or about 0.46%. The underlying mechanism isn’t well understood, and no reliable treatment exists yet. Risk factors may include genetic predisposition, prior exposure to certain medications, and pre-existing conditions that affect how the brain adapts to chemical changes. PSSD is diagnosed by ruling out all other possible causes of sexual dysfunction, including the depression itself.
One important caution: PSSD can be misdiagnosed as a return of depression, leading clinicians to restart the very medication that caused the problem. If your sexual function was normal before starting an SSRI and doesn’t return after stopping, that distinction matters.